Journal: Immunology

Article Title: Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.

PMID/MRN: 27676456

Publication Date: 2016-Sep-27

Abstract:

There is a current lack of effective mucosal vaccines against major gastroenteric pathogens and particularly against Helicobacter pylori, a chronic infection that can lead to peptic ulcers and gastric cancer in a sub-population of infected individuals. Mucosal CD4 + T cell responses have been shown to be essential for vaccine-induced protection against H. pylori infection. The current study addresses the influence of the adjuvant and site of mucosal immunization on early CD4 + T cell priming to H. pylori antigens. The vaccine formulation consisted of H. pylori lysate antigens and mucosal adjuvants, cholera toxin (CT) or a detoxified double mutant heat-labile enterotoxin from Escherichia coli (dmLT) which were administered either by the sublingual or intragastric route. We report that in vitro, adjuvants CT and dmLT induce upregulation of pro-inflammatory gene expression in purified dendritic cells and enhance the H. pylori specific CD4 + T cell response including IL-17A, IFN? and TNF? secretion. In vivo, sublingual immunization led to an increased frequency of IL-17A + , IFN? + and TNF? + secreting CD4 + T cells in the cervical lymph nodes compared to in the mesenteric lymph nodes after intragastric immunization. Subsequently, IL-17A + cells were visualized in the stomach of sublingually immunized and challenged mice. In summary, our results suggest that addition of an adjuvant to the vaccine clearly activated dendritic cells which in turn, enhanced CD4 + T cell cytokine IL-17A, IFN? and TNF? responses, particularly in the cervical lymph nodes after sublingual vaccination. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.